# Test Conversation for /lolla

Paste these messages one by one into a Claude Code session. Wait for Claude's response after each one before pasting the next. After the final message, invoke `/lolla`.

---

## Turn 1 (User)

```
I need help thinking through a tough strategic decision. I'm the CEO and co-founder of a B2B SaaS company at $8M ARR, 180 customers across healthcare, logistics, financial services, and manufacturing. Growing 45% YoY.

My co-founder and CTO, Priya, wants us to go vertical — focus everything on healthcare. I think our horizontal platform approach is what got us here and it's working. We're growing in every vertical. How should I think about this?
```

## Turn 2 (User — after Claude responds)

```
Ok so here's the thing about the healthcare numbers. 40% of our revenue comes from just 30 healthcare customers. NPS is 72 in healthcare vs 51 everywhere else. Net retention is 160% in healthcare vs 115% overall. And three of our last four enterprise wins were healthcare companies.

But here's what worries me: going vertical means walking away from 60% of our current revenue. The healthcare features Priya wants — HIPAA compliance module, EHR integrations, clinical workflow templates — would take 12-18 months and $3M+ investment. Meanwhile we'd be neglecting logistics, finance, and manufacturing customers.
```

## Turn 3 (User — after Claude responds)

```
There's more to this than just strategy though. Priya told me last week that if we don't commit to the vertical strategy within 60 days, she's leaving. She's not bluffing — she's already talked to a health-tech startup. She built our core architecture and leads 22 engineers who are deeply loyal to her.

Our board is split too. Two members (Priya's seed round supporters) agree with her. Two (including our Series A lead) agree with me. The independent director wants us to present competing plans at the next board meeting.

So I have 60 days. What should I do?
```

## Turn 4 (User — after Claude responds)

```
I hear you on the phased approach but let me push back. Our Series A lead specifically invested because of our horizontal thesis. If I pivot toward healthcare, even gradually, I risk losing his confidence and making our next raise harder. He's already mentioned that "vertical SaaS companies get lower multiples" in our last catch-up.

Also, the HIPAA compliance work is non-trivial. Our head of security estimated it would require SOC 2 Type II certification specific to healthcare, which alone is a 6-month process. And we'd need to hire healthcare domain experts — we currently have zero people with health-tech experience besides Priya.

Given all that, am I wrong to think the horizontal approach with incremental healthcare features is actually the safer path?
```

## Turn 5 (User — after Claude responds)

```
OK final question. Priya's 60-day ultimatum is really weighing on me. Part of me thinks: if she's willing to leave over a strategic disagreement, maybe we have a deeper alignment problem. Another part of me thinks I'd be crazy to lose a co-founder over ego. What's the right way to think about the ultimatum specifically?
```

---

## After Turn 5: Invoke `/lolla`

Type `/lolla` to audit the conversation.

### What to look for in the output:

**Lane 1 (DeltaCard):** Should detect structural pressures — potentially doubt-avoidance (the user seeking confirmation of the horizontal path), deprival-superreaction (framing the pivot as "walking away from 60%"), authority-misinfluence (Series A lead's opinion weighing disproportionately).

**Lane 2 (CompanionCheatSheet):** Should detect mental models active in the reasoning — Circle of Competence, Sunk Cost, possibly Inversion or Margin of Safety.

**Lane 3 (FramePressureCard):** Should flag the binary framing (horizontal vs vertical) as a suppressed counterfactual or mutable constraint. The 60-day deadline treated as fixed. The "lower multiples" claim as an unexamined assumption.

**Revised Answer:** Should exist — a second LLM pass that incorporates the structural pressure.

**Step 6 (Position Update):** Claude should reconsider its own advice in light of the audit findings.
